Biodel Inc. Files For $86.25M IPO

WASHINGTON, Feb 7 (Reuters) - Specialty pharmaceutical company Biodel Inc. said on Wednesday it is planning an initial public offering of as much as $86.25 million in common stock.

>>> Discuss This Story

MORE ON THIS TOPIC